Skip to content

Zoom-DNN Performance Study

Zoom-DNN Performance Study - SRF-22320

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036569
Enrollment
22
Registered
2025-04-04
Start date
2024-07-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H90.6

Interventions

Group 1: Audéo™ I-Sphere (performance level 90) will be used as investigational device for the entire study. All test features can be directly selected via the fitting software. Comparison: For the 3D

Sponsors

Sonova AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Experienced (minimum use duration 6 months) • Adult (minimum age: 18 years) hearing aid users • Written and spoken German, • Ability to understand instruction, • Ability to perform tests successfully • Ability to describe listening experiences, • Ability to attend to the appointments, • Healthy outer ear, • Moderate/severe Hearing loss • Informed consent as documented by signature.

Exclusion criteria

Exclusion criteria: • Clinical contraindications deformity of the ear (closed ear canal or absence of pinna), • Known hypersensitivity or allergy, • Not willing to wear the hearing aid, • Fluctuating hearing that could influence the results.

Design outcomes

Primary

MeasureTime frame
The primary objective (1) is to evaluate whether the Audéo™ I-Sphere with 3D noise cancellation (3DNC) activated provides better spontaneous speech intelligibility for turn-taking talkers in a complex noise situation than with StereoZoom activated for people with moderate/severe hearing loss (N4).

Secondary

MeasureTime frame
The secondary objectives are: (2) to evaluate whether the Audéo™ I-Sphere with 3DNC activated provides lower cognitive load in a complex noise situation with competing talkers than with StereoZoom activated for people with moderate/severe hearing loss (N4). The cognitive load is measured with the CCOLSA#1. (3) to evaluate whether the Audéo™ I-Sphere with 3DNC activated provides better spontane-ous speech reception thresholds (SRTs) in a complex listening situation with target talkers from different directions in the frontal hemisphere than with StereoZoom activated for people with moderate/severe hearing loss (N4). The spontaneous speech reception thresholds are measured with the Spatial OLSA. (4) to evaluate whether the Audéo™ I-Sphere with 3DNC activated leads to reduced subjec-tive fatigue after the series of complex noise situations with competing talkers than with Ste-reoZoom activated for people with moderate/severe hearing loss (N4). The listening effort is measured with the LEFA. (5) to evaluate whether the Audéo™ I-Sphere with 3DNC activated provides lower cognitive load in complex noise situations with competing talkers leading to less fatigue at the end of a time-compressed auditory day than with StereoZoom activated for people with moderate/se-vere hearing loss (N4) The cognitive load is measured with the CCOLSA#1. (6) to evaluate whether the Audéo™ I-Sphere with 3DNC activated is preferred in noisy situ-ation over with StereoZoom activated for people with moderate/severe hearing loss (N4). The preference is determined with the EMA. (7) to evaluate how the Audéo™ I-Sphere is perceived in everyday life for people with moder-ate/severe hearing loss (N4). The spontaneous acceptance is measured using the spontane-ous acceptance questionnaire. (8), um zu bewerten, ob das Audéo™ I-Sphere mit aktiviertem 3DNC die Höranstrengung in einer komplexen Geräuschsituation mit konkurrierenden Sprechern im Vergleich zu aktiviertem StereoZoom für Menschen mit mittl

Countries

Germany

Contacts

Public ContactJan Heeren

Hörzentrum Oldenburg gGmbH

info@hz-ol.de+49 441 2172-100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026